| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-38 |
| filingDate |
1984-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fff5d9fe83a88bfcf2de93bfb61ae626
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27864fe4f205443c401151a91b7977fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bdd45507cf4acde8a60ec9bfb93a0d6 |
| publicationDate |
1985-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0142057-A2 |
| titleOfInvention |
Thiazoloquinazoline derivatives, their preparation and pharmaceutical compositions containing same |
| abstract |
Compounds of the formulan wherein R 1 is hydrogen, lower alkyl, lower cycfoalkyl, lower alkoxy, hydroxy frafogen lower alkylthio lower alkylsulfirryl lower alkylsulfonyl, di-lower alkyl- NiCH 2 )nO- or 2-hydroxyethoxy; n is 2 to 7; R 2 is hydrogen lower alkyl or lower alkoxy; R 5 is hydrogen or lower alkyl; provided that if R 2 is otherthan hydrogen, R 5 is hydrogen; O is one of the groupsn n wherein R 3 is hydrogen or methyl; R 4 is hydrogen or lower alkyl; R 5 is lower alkyl; m is 1 to 7; w is zero or one; Y is-NH-; -NH-CH 2 ; -0-; or -S.; and A is an unsubstituted or substituted heterocyclic radical; and pharmaceutically acceptable acid addition salts thereof are described. The compounds of formula I are useful as anti-allergic agents as well as agents for the treatment of vascular disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6455554-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9522329-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6492399-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6441006-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6441007-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6627648-B1 |
| priorityDate |
1983-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |